SCHEMBL7369145

SCHEMBL7369145

COc1ccc(C(C)=O)c(CCC(=O)O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.63
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
CYP3A4 P08684 2/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
HSD17B10 Q99714 3/20 0.50
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
PKM P14618 1/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 1/20 0.47
FFAR1 O14842 1/20 0.47
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
KDM4E B2RXH2 2/20 0.46
GPR17 Q13304 1/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2558133 0.84 HSD17B10 (0.66) POLBALDH1A1HPGDCYP3A4MAPK1
SCHEMBL7368806 0.82 POLB (0.79) POLBALDH1A1HPGDHTTHSD17B10
SCHEMBL5730634 0.82 ALDH1A1 (0.62) ALDH1A1HPGDCYP3A4MAPK1HTT
SCHEMBL7373176 0.81 CYP3A4 (0.48) POLBALDH1A1HPGDCYP3A4MAPK1
SCHEMBL1350452 0.81 ALDH1A1 (0.54) ALDH1A1HPGDCYP3A4MAPK1HSD17B10
SCHEMBL20232560 0.81 POLB (0.71) POLBALDH1A1HPGDHTTHSD17B10
SCHEMBL30436820 0.81 HSD17B10 (0.71) POLBHSD17B10MTNR1AMTNR1B
SCHEMBL491188 0.81 HSD17B10 (0.71) POLBHSD17B10MTNR1AMTNR1B
SCHEMBL14864225 0.80 ALDH1A1 (0.61) ALDH1A1HPGDCYP3A4MAPK1HTT
SCHEMBL6583328 0.80 ALDH1A1 (0.53) POLBALDH1A1HPGDCYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000031-A4 VITRONECTIN RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORP (US) 2001-08-16 EP disclosed
US-6239138-B1 TREATMENT OF INFLAMMATION, CANCER, CARDIOVASCULAR DISORDERS, SUCH AS ATHEROSCLEROSIS AND RESTENOSIS, OSTEOPOROSIS, BENZOCYCLOHEPTENYL IN WHICH A NITROGEN-CONTAINING SUBSTITUENT IS PRESENT ON THE AROMATIC SIX-MEMBERED RING AND AN ALIPHATIC SMITHKLINE BEECHAM CORPORATION 2001-05-29 US disclosed
EP-1000031-A1 VITRONECTIN RECEPTOR ANTAGONIST SmithKline Beecham Corporation (US) 2000-05-17 EP disclosed
WO-1999005107-A1 VITRONECTIN RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORPORATION (US) 1999-02-04 WO disclosed